DDX46在恶性肿瘤发生发展中的作用

霍玉; 鞠云鹤; 王宇涛; 曾雅林; 梁俊峰

doi:10.12259/j.issn.2095-610X.S20241123

DDX46在恶性肿瘤发生发展中的作用

doi: 10.12259/j.issn.2095-610X.S20241123

1.
昆明医科大学第三附属医院放疗科云南昆明　650118
2.
昆明医科大学动物实验部，云南昆明　650500

基金项目: 国家自然科学基金资助项目（82160562）；云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目（202001AC070140）

详细信息

作者简介:
霍玉（1999～），女，云南昆明人，在读硕士研究生，主要从事消化肿瘤的临床与研究工作

通讯作者:
鞠云鹤，E-mail：yunhe_ju@sina.com

中图分类号: R73-3
计量
- 文章访问数: 259
- HTML全文浏览量: 220
- PDF下载量: 18
- 被引次数: 0
出版历程
- 收稿日期: 2024-08-25
- 网络出版日期: 2024-11-09
- 刊出日期: 2024-11-25

The Role of DDX46 in the Occurrence And Development of Malignant Tumors

1.
Dept. of Radiotherapy，The 3rd Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital，Kunming Yunnan 650118
2.
Dept. of Experimental Animals，Kunming Medical University， Kunming Yunnan 650500，China)

摘要

摘要: 随着分子生物学的深入发展，人们对癌症发生机制的理解愈发深刻。近年来，大量研究发现DDX46在结直肠癌、食管鳞状细胞癌、胃癌等多种恶性肿瘤中过表达能促进多种恶性肿瘤细胞的增殖、侵袭和迁移，抵抗细胞凋亡，并参与细胞周期，因此可能成为潜在的抗肿瘤药物靶点和标志物。为了更直观地了解DDX46在癌症中的作用，系统地阐述其在肿瘤发生和发展的各个方面的功能及相关机制，为DDX46靶向药物的研发提供新思路。
- 分子生物学 /
- DDX46 /
- 癌症 /
- RNA解旋酶
Abstract: With the deepening development of molecular biology, people's understanding of the mechanisms of cancer occurrence is becoming increasingly profound. In recent years, DDX46 has been found to be overexpressed in various cancers such as colorectal cancer, esophageal squamous cell carcinoma, and gastric cancer. It can promote the proliferation of various malignant tumor cells, activate invasion and migration, resist cell apoptosis, and participate in the cell cycle. Therefore, it may become a potential target and biomarker for anti-tumor drugs. To provide a more intuitive understanding of the role of DDX46 in cancer, we systematically describe its functions and related mechanisms in various aspects of tumorigenesis and development. It provides a new idea for the research and development of DDX46 targeted drugs.
- Molecular biology /
- DDX46 /
- Cancer /
- RNA helicase

HTML全文

表 1 DDX46在多种肿瘤中的表达及临床特征

Table 1. Expression and clinical characteristics of DDX46 in various tumors

癌症类型	mRNA/蛋白质	高/低表达	百分比（%）	临床特征	胞质/核	参考文献
胶质母细胞瘤	mRNA and Protein	高				[18]
食管鳞状细胞癌	mRNA and Protein	高	32/69（46）		主要在胞核	[7]
		低	30/69（43）		主要在胞核
乳腺癌	Protein	高		高级别组织学分级和淋巴结转移显著相关，与更具有侵袭性的肿瘤表型相关	主要在胞核	[20]
胃癌	mRNA	高				[5]
结直肠癌	Protein	高	99/123（81）		主要在胞核	[6]
		低	19/123（15）	粘液腺癌比例高（8/11 73%）	主要在胞核
骨肉瘤	mRNA and Protein	高				[21]
皮肤鳞状细胞癌	mRNA and Protein	高				[19]
卵巢癌	Protein	高				[22]
慢性淋巴细胞白血病				高表达生存期短		[23]

下载: 导出CSV

参考文献(30)

[1]	Zhang Z M,Yang F,Zhang J. Crystal structure of Prp5p reveals interdomain interactions that impact spliceosome assembly[J]. Cell Rep,2013,5(5):1269-1278. doi: 10.1016/j.celrep.2013.10.047
[2]	Will C L,Urlaub H,Achsel T. Characterization of novel SF3b and 17S U2 snRNP proteins,including a human Prp5p homologue and an SF3b DEAD-box protein[J]. EMBO,2002,21(18):4978-4988. doi: 10.1093/emboj/cdf480
[3]	Zheng Q,Hou J,Zhou Y. The RNA helicase DDX46 inhibits innate immunity by entrapping m6A-demethylated antiviral transcripts in the nucleus[J]. Nat Immunol,2017,18(10):1094-1103.
[4]	Yang F,Bian T,Zhan X. Mechanisms of the RNA helicases DDX42 and DDX46 in human U2 snRNP assembly[J]. Nat Commun,2023,14(1):897. doi: 10.1038/s41467-023-36489-x
[5]	Chen L,Xu M,Zhong W. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway[J]. Exp Cell Res,2020,399(1):112448.
[6]	Li M,Ma Y,Huang P. Lentiviral DDX46 knockdown inhibits growth and induces apoptosis in human colorectal cancer cells[J]. Gene,2015,560(2):237-244. doi: 10.1016/j.gene.2015.02.020
[7]	Li B,Li Y M,He W T. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells[J]. Oncol Rep,2016,36(1):223-230. doi: 10.3892/or.2016.4803
[8]	Bleichert F,Baserga S J. The long unwinding road of RNA helicases[J]. Mol Cell,2007,27(3):339-352. doi: 10.1016/j.molcel.2007.07.014
[9]	Tanner N K, Linder P. DExD/H box RNA helicases: From generic motors to specific dissociation functions[J]. Mol Cell,2001,8(2):251-262.
[10]	Xu Y Z,Newnham C M,Kameoka S. Prp5 bridges U1 and U2 snRNPs and enables stable U2 snRNP association with intron RNA[J]. Embo J,2004,23(2):376-385. doi: 10.1038/sj.emboj.7600050
[11]	Shao W. A U1-U2 snRNP interaction network during intron definition[J]. Mol Cell Biol,2012,32(2):470-478. doi: 10.1128/MCB.06234-11
[12]	Will C L,Lührmann R. Spliceosome structure and function[J]. Cold Spring Harbor Perspect Biol,2011,3(7):a003707.
[13]	Liang W W,Cheng S C. A novel mechanism for Prp5 function in prespliceosome formation and proofreading the branch site sequence[J]. Genes Dev,2015,29(1):81-93. doi: 10.1101/gad.253708.114
[14]	Gama-Brambila R A,Chen J,Zhou J. A PROTAC targets splicing factor 3B1[J]. Cell Chem Biol,2021,28(11):1616-1627. doi: 10.1016/j.chembiol.2021.04.018
[15]	Yoshida K,Ogawa S. Splicing factor mutations and cancer[J]. Wires Rna,2014,5(4):445-459. doi: 10.1002/wrna.1222
[16]	Xu Y Z,Query C C. Competition between the ATPase Prp5 and branch region-U2 snRNA pairing modulates the fidelity of spliceosome assembly[J]. Mol Cell,2007,28(5):838-849. doi: 10.1016/j.molcel.2007.09.022
[17]	Abu Dayyeh B K,Quan T K,Castro M. Probing interactions between the U2 small nuclear ribonucleoprotein and the DEAD-box protein,Prp5[J]. J Biol Chem,2002,277(23):20221-20233. doi: 10.1074/jbc.M109553200
[18]	Ma J,Gao Z,Liu X. DDX46 accelerates the proliferation of glioblastoma by activating the MAPK-p38 signaling[J]. J Buon,2021,26(5):2084-2089.
[19]	Lin Q,Jin H J. DDX46 silencing inhibits cell proliferation by activating apoptosis and autophagy in cutaneous squamous cell carcinoma[J]. Mol Med Rep,2020,22(5):4236-4242.
[20]	Ma Z,Song J. The role of DDX46 in breast cancer proliferation and invasiveness: A potential therapeutic target[J]. Cell Biol Int,2022,47(1):283-291.
[21]	Jiang,F,Zhang. Knockdown of DDX46 Inhibits the invasion and tumorigenesis in osteosarcoma cells[J]. Oncol Res,2016,25(3):417-425.
[22]	Asher V , Warren A , Shaw R. The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line[J]. Cancer Cell International,2011,11(1):1-7.
[23]	Admoni-Elisha L,Nakdimon I,Shteinfer A. Novel biomarker proteins in chronic lymphocytic leukemia: Impact on diagnosis,prognosis and treatment[J]. PLos One,2016,11(4):e0148500. doi: 10.1371/journal.pone.0148500
[24]	Yang J, Nie J, Ma X. Targeting PI3K in cancer: Mechanisms and advances in clinical trials[J]. Mol Cancer, 18(1): 26.
[25]	Faes S,Dormond O. PI3K and AKT: Unfaithful partners in cancer[J]. Int J Mol Sci,2015,16(9):21138-21152. doi: 10.3390/ijms160921138
[26]	Peter M E. Programmed cell death: Apoptosis meets necrosis[J]. Nature,2011,471(7338):310-312. doi: 10.1038/471310a
[27]	Tanaka K, Kumano K, Ueno H. Intracellular signals of lung cancer cells as possible therapeutic targets[J]. Cancer Sci,2015,106(5):489-496.
[28]	You X,Cui H,Yu N. Knockdown of DDX46 inhibits trophoblast cell proliferation and migration through the PI3K/Akt/mTOR signaling pathway in preeclampsia[J]. Open Life Sci,2020,15(1):400-408. doi: 10.1515/biol-2020-0043
[29]	Li A,He J,Zhang Z. Integrated bioinformatics analysis reveals marker genes and potential therapeutic targets for pulmonary arterial hypertension[J]. Genes (Basel),2021,12(9):1339. doi: 10.3390/genes12091339
[30]	Hirabayashi,R,Hozumi. Ddx46 is required for multi-lineage differentiation of hematopoietic stem cells in zebrafish[J]. Stem Cells Dev,2013,22(18):2532-2542.

相关文章(20)

[1]	曾维兴, 何永文. 青蒿素及其衍生物在癌症治疗中的作用机制研究进展, 昆明医科大学学报.
[2]	付兰博, 阮朝列, 陈昶旭, 高羽, 鲍晓琳, 刘伯川, 周健, 李卫东. 1株悬浮培养的Vero细胞驯化及其生物学特性研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240602
[3]	吴琼, 李娜, 徐瑜涓. 基于Citespace肝癌症状群文献可视化分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241109
[4]	王群, 孙雨欣, 王海峰. 脂滴表面蛋白perilipin家族在癌症中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230812
[5]	李晓涛, 王海峰, 王剑松. FBP1在癌症中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211237
[6]	陈晓星, 翟广, 戈佳云, 魏东, 施智甜, 郭志唐, 王滔, 赵松凌, 王连敏, 王琳. DACH1在肝癌中的生物学作用及机制, 昆明医科大学学报.
[7]	李晨, 马东艳, 李飞丽, 何敏, 杨娜, 麦晓蓉, 杨春梅. 基于表达性艺术治疗的女性癌症病房照护模式创新与实践, 昆明医科大学学报.
[8]	周灵, 左瑞玲, 马莉, 杨艳阳, 胡雪姣, 谢琳. 癌症患者化疗前焦虑对化疗后恶心呕吐的影响, 昆明医科大学学报.
[9]	李晓涛, 王海峰, 王剑松. LASS2生物学功能的研究进展, 昆明医科大学学报.
[10]	吴江, 王云华, 姚丽琴, 费严焰, 谢杉, 石涛. 情境式健康教育模式在癌症患者疼痛教育中的应用, 昆明医科大学学报.
[11]	吴夕, 徐婷婷, 沈丽达, 谢琳, 胡凤娣, 龙庭凤, 董坚. 云南省贫困、偏远、少数民族聚集地区癌症相关危险因素现状调查, 昆明医科大学学报.
[12]	杨芳, 杨银峰, 李清, 狄勇, 何永蜀, 朱月春. “四合二”生命基础整合课程的设计与实践, 昆明医科大学学报.
[13]	周玲, 钟琼, 王敏, 谭思, 刘永秀. 医联体医护一体化在癌症患者居家镇痛中的应用, 昆明医科大学学报.
[14]	朱宇, 何易晓, 杨丽娟, 王芳. 钙离子稳态失调与癌症增殖转移关系的研究进展, 昆明医科大学学报.
[15]	胡玉崇, 陆景坤, 崔梦瑶. PTEN及Caspase-3可能参与卵巢癌铂类耐药的机制, 昆明医科大学学报.
[16]	李思熳, 李树德, 武静, 李治纲, 朱月春. PBL结合摄像反馈在留学生分子生物学实验教学中的应用, 昆明医科大学学报.
[17]	罗赛美. 癌症患者生命质量测定量表体系之前列腺癌量表QLICP-PR的条目筛选, 昆明医科大学学报.
[18]	张照莉. 癌症患者心理痛苦动态评估及干预的实践, 昆明医科大学学报.
[19]	李丹娜. 癌症患者生命质量的纵向研究现状, 昆明医科大学学报.
[20]	杨银峰. 虚拟实验技术在分子生物学实验教学中的应用, 昆明医科大学学报.